Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| TWST | CLUSTER | neutral | 2/10 | Five Twist Bioscience insiders, including CEO Emily Leproust and President/COO Patrick Finn, sold a combined $884K in op | Aug 6, 2026 |
| FATE | CLUSTER | bearish | 5/10 | Two insiders at Fate Therapeutics, including the CEO, sold a combined $204K worth of shares in open-market transactions | Aug 6, 2026 |
| BEAM | CLUSTER | mixed | 5/10 | A cluster of insider selling at Beam Therapeutics materialized over June 26-30, 2026, totaling $8.95M. The CEO exercised | Jul 2, 2026 |
| BEAM | CLUSTER | bearish | 4/10 | CEO John M. Evans exercised options and sold shares worth ~$1.26M, while 10% owner FMR LLC sold 251,488 shares (~$8.87M) | Jul 2, 2026 |
| TWST | CLUSTER | neutral | 2/10 | Three Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $203K in open-market transactions on June | Jun 25, 2026 |
| RXRX | CLUSTER | neutral | 2/10 | Three directors at Recursion Pharmaceuticals sold a total of $271K in open-market transactions over a 7-day window. The | Jun 5, 2026 |
| ILMN | CLUSTER | neutral | 2/10 | A cluster of insider sales totaling $11.62M occurred over the last week, dominated by Director Keith A. Meister's sale o | Jun 4, 2026 |
| TWST | CLUSTER | neutral | 3/10 | Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (vi | Jun 2, 2026 |
| ILMN | CLUSTER | neutral | 3/10 | Three insiders at Illumina (ILMN) sold a total of ~$19.6M in open-market transactions over a 5-day window ending June 1, | Jun 1, 2026 |
| ILMN | CLUSTER | neutral | 2/10 | Two Illumina insiders — the Chief Legal Officer and VP/Chief Accounting Officer — sold a combined $178K in open-market s | Jun 1, 2026 |
| TWST | CLUSTER | neutral | 3/10 | A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-m | Jun 1, 2026 |
| TWST | CLUSTER | bearish | 5/10 | A substantial insider selling cluster at Twist Bioscience, concentrated on May 21-26, 2026, with CEO Emily Leproust alon | May 28, 2026 |
| TXG | CLUSTER | neutral | 2/10 | Two insiders at 10x Genomics, including the CFO, sold a combined $652K in open-market sales on May 22, 2026, at ~$24.44/ | May 27, 2026 |
| TWST | CLUSTER | neutral | 3/10 | Six TWST insiders—including the CEO, CFO, and COO—collectively sold 16,796 shares for ~$807K on May 21, 2026, all at $53 | May 26, 2026 |
| ILMN | CLUSTER | neutral | 4/10 | Director Keith Meister sold 171,932 shares for $24.96M in open-market sales, while SVP Jakob Wedel Christensen sold 700 | May 14, 2026 |
| RXRX | CLUSTER | neutral | 2/10 | Two directors sold a total of $240K in open-market stock following the Q1 earnings release, but this represents only 0.0 | May 8, 2026 |
| TWST | CLUSTER | neutral | 4/10 | Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the past week, with the ma | Apr 23, 2026 |
| DNA | CLUSTER | bearish | 6/10 | Four insiders, including executives and a 10% owner, sold $2.52M in shares over a 7-day period, with open-market sales a | Apr 20, 2026 |
| DNA | CLUSTER | bearish | 6/10 | Three corporate insiders at Ginkgo Bioworks (DNA) conducted open-market share sales over a 7-day period, totaling approx | Apr 13, 2026 |
| RXRX | CLUSTER | neutral | 3/10 | Two directors at Recursion Pharmaceuticals sold a combined $217K in shares over a 7-day window, with no open-market buyi | Apr 8, 2026 |
| RXRX | CLUSTER | neutral | 3/10 | Director Christopher Gibson sold 40,000 shares in an open-market transaction for $130,000, while also converting derivat | Mar 25, 2026 |
| CRSP | CLUSTER | neutral | 3/10 | CRISPR Therapeutics CFO Prasad Raju sold $173,460 worth of shares in an open-market transaction, while both the CFO and | Mar 24, 2026 |
| TWST | CLUSTER | neutral | 3/10 | Three insiders at Twist Bioscience sold shares in a coordinated open-market transaction on March 20, 2026, including CEO | Mar 24, 2026 |
| TWST | CLUSTER | bearish | 5/10 | Three insiders at Twist Bioscience sold shares in a coordinated 7-day window, including CEO Emily Leproust, who sold $11 | Mar 10, 2026 |
| PACB | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Pacific Biosciences of California (PACB) over the past week consists primarily of n | Mar 5, 2026 |
| TXG | CLUSTER | neutral | 4/10 | 10x Genomics CEO Saxonov sold $324K in open-market shares while receiving a large non-cash stock award; CFO and another | Mar 4, 2026 |
| NTLA | CLUSTER | neutral | 3/10 | Intellia Therapeutics insiders executed a mix of open-market sales and stock awards over the past week. Two executives s | Mar 3, 2026 |
| TXG | CLUSTER | neutral | 3/10 | A recent insider trading cluster at 10x Genomics includes a non-cash share award to CFO Taich Adam and an open-market sa | Mar 2, 2026 |
| TXG | CLUSTER | bearish | 6/10 | Four insiders at 10x Genomics sold shares in the past week, including CEO Serge Saxonov and CFO Adam Taich, with total o | Feb 27, 2026 |
| TWST | CLUSTER | bearish | 6/10 | Six insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and other executives, sold shares in a coordinated o | Feb 26, 2026 |